BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,251,000 | – | 1,971,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |